Ablamap® System

GUDID 00860457001568

The Ablamap® System is an electrophysiology mapping system for assisting in the diagnosis of complex cardiac arrhythmias. The system consists of several hardware elements including an amplifier, cart, monitor, and workstation that contains proprietary mapping software. Signals are transmitted from a 64-electrode mapping “basket” catheter, through the amplifier, to the workstation, processed by the mapping software, and the results are displayed on the monitor.

Ablacon Inc.

Cardiac mapping system computer
Primary Device ID00860457001568
NIH Device Record Key7cfcbc68-fb05-4ee0-9f15-b77f1912faa7
Commercial Distribution StatusIn Commercial Distribution
Brand NameAblamap® System
Version Model NumberAB-0007
Company DUNS106083214
Company NameAblacon Inc.
Device Count1
DM Exempttrue
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numbertrue
Manufacturing Datetrue
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS100860457001568 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

DQKComputer, Diagnostic, Programmable

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2023-12-15
Device Publish Date2023-12-07

Devices Manufactured by Ablacon Inc.

00860457001513 - Ablacath Catheter Extension Cable2025-03-03 Catheter extension cable
00860457001520 - Ablacath System Interconnect Cable2025-03-03 System interconnect cable
00860457001544 - Ablacon™ Mapping Catheter2023-12-15 The Ablacath™ Mapping Catheter may be used to detect electrical potentials from the endocardial surfaces of the heart. These
00860457001551 - Ablacon™ Mapping Catheter2023-12-15 The Ablacath™ Mapping Catheter may be used to detect electrical potentials from the endocardial surfaces of the heart. These
00860457001568 - Ablamap® System2023-12-15The Ablamap® System is an electrophysiology mapping system for assisting in the diagnosis of complex cardiac arrhythmias. The system consists of several hardware elements including an amplifier, cart, monitor, and workstation that contains proprietary mapping software. Signals are transmitted from a 64-electrode mapping “basket” catheter, through the amplifier, to the workstation, processed by the mapping software, and the results are displayed on the monitor.
00860457001568 - Ablamap® System2023-12-15 The Ablamap® System is an electrophysiology mapping system for assisting in the diagnosis of complex cardiac arrhythmias. The s

Trademark Results [Ablamap]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ABLAMAP
ABLAMAP
79177944 4986020 Live/Registered
Ablacon Inc.
2015-09-10

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.